Firm

Anapol Weiss Expands, Integrating Five-Attorney Mass Tort Firm in Washington, DC

by

Washington, D.C. — In a strategic move to strengthen its foothold in the mass tort litigation landscape, the prominent law firm Anapol Weiss has recently announced its acquisition of a specialized five-attorney boutique based in the nation’s capital. This acquisition not only signifies Anapol Weiss’s expansion into new geographical territories but also broadens its expertise and resources particularly in complex mass tort cases. The boutique firm, which has carved out a niche in mass tort litigation, brings a wealth of experience and a track record of substantial settlements in pharmaceutical and medical device litigation, areas … Read more

Anapol Weiss Expands with Acquisition of 5-Lawyer Mass Tort Firm in Washington DC

by

Philadelphia-based law firm Anapol Weiss announced its strategic acquisition of the Washington D.C.-based mass tort boutique, which includes a team of five attorneys. This move signifies Anapol Weiss’s commitment to expanding its presence in handling mass tort litigation, a niche area of law specializing in large-scale civil actions involving numerous plaintiffs against corporate or institutional defendants. The boutique firm, which has built a strong reputation within the capital, is recognized for its work in consumer product safety, pharmaceutical medication, and environmental law cases. This acquisition not only widens Anapol Weiss’s geographic footprint but also deepens … Read more

Urgent Investor Alert: Participate in the DexCom, Inc. Class Action Lawsuit by October 2024, Legal Firm Levi & Korsinsky Offers Guidance on Rights – DXCM

by

New York, NY – A recent class-action lawsuit filed against DexCom, Inc., a prominent player in the diabetes management technology sector, claims that the company engaged in practices which may have misled investors. The suit centers on possible violations of federal securities laws. According to the law firm Levi & Korsinsky, the lead plaintiff filings must be submitted by October 21, 2024. Shareholders who incurred damages from investments in DexCom’s stock during a specified period are eligible to discuss their rights and potentially participate in the lawsuit. The allegations suggest that DexCom may have provided … Read more

Arbor Realty Trust Faces Class Action Lawsuit for Alleged Securities Fraud; Legal Firm Urges Shareholders to Claim Rights by September 2024

by

NEW YORK — Investors holding shares in Arbor Realty Trust, Inc. are currently faced with a looming securities fraud class action lawsuit, making it crucial for them to review their legal options promptly. Legal experts emphasize the significance of the deadline on September 30, 2024, for shareholders to join the class action and assert their rights. At the heart of the lawsuit is the allegation that Arbor Realty Trust may have issued materially misleading business information to the investing public, thus potentially violating federal securities laws. This type of lawsuit not only highlights the compliance … Read more